SEC Form D · filed September 9, 2016
Adgero Biopharmaceuticals Holdings, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Alastair Barbour · Edinburgh, United KingdomDirectorMichael A. Jenkins · New York, NYDirectorRobert B. Knapp · New York, NYExecTim P. Mcinerney · Princeton, NJDirectorAllen P. Bloom · Princeton, NJDirectorNicolai Wadstrom · San Francisco, CADirectorFrank P. Pilkiewicz · Princeton, NJExec · DirectorMark Way · Hamilton, BermudaExec · DirectorSteve P. Rychnovsky · Princeton, NJExecRoman P. Perez-Soler · Princeton, NJDirectorRobert A. Granieri · New York, NYDirectorCarrie M. Bass · Dallas, TXDirectorDavid Dunn · Wilton, CTDirectorLinzy O. Scott · Atlanta, GADirectorDavid P. Hochman · Princeton, NJDirectorRagan Young · Dallas, TXExec · DirectorLindsay Watson · Hamilton, BermudaDirectorHelen L. Francis · Westport, CTExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗